SCHEMBL16558015

SCHEMBL16558015

COc1cc2ccnc(C(C)(C)C)c2cc1CO

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.45
PDE4A P27815 2/20 0.42
PDE4B Q07343 2/20 0.42
PDE4C Q08493 2/20 0.42
PDE4D Q08499 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 2/20 0.41
GAA P10253 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
PDE10A Q9Y233 4/20 0.40
ACHE P22303 3/20 0.40
PDE3B Q13370 3/20 0.40
PDE3A Q14432 3/20 0.40
USP2 O75604 2/20 0.40
ALDH1A1 P00352 2/20 0.40
LMNA P02545 2/20 0.40
CYP3A4 P08684 2/20 0.40
MAPK1 P28482 2/20 0.40
HIF1A Q16665 2/20 0.40
RAB9A P51151 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14090711 0.84 CYP3A4 (0.50) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL14850177 0.76 EGFR (0.40) PDE4APDE4BPDE4CPDE4DPDE10A
SCHEMBL22325312 0.75 APAF1 (0.45) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL14115088 0.72 PDE10A (0.49) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL14122886 0.71 SRC (0.45) ALDH1A1MAPK1KDM4EFGFR1SRC
SCHEMBL16558014 0.71 HTT (0.46) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL10371865 0.71 PDE10A (0.66) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL31207129 0.71 PDE10A (0.66) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL18027461 0.70 PDE4A (0.37) PDE4APDE4BPDE4CPDE4DPDE10A
SCHEMBL16558019 0.70 PDE4A (0.37) PDE4APDE4BPDE4CPDE4DPDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160243085-A1 SUBSTITUTED TRIAZOLES USEFUL AS AXL INHIBITORS MIDCAP FINANCIAL TRUST 2016-08-25 US disclosed
US-9353126-B2 Substituted triazoles useful as Axl inhibitors RIGEL PHARMACEUTICALS, INC. (US) 2016-05-31 US disclosed
US-20150072959-A1 SUBSTITUTED TRIAZOLES USEFUL AS AXL INHIBITORS MIDCAP FINANCIAL TRUST 2015-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150072959-A1 SUBSTITUTED TRIAZOLES USEFUL AS AXL INHIBITORS AXL, TYRO3, MERTK TNF 4374/4885PDE4A 1910/4885PDE4B 1781/4885
US-20160243085-A1 SUBSTITUTED TRIAZOLES USEFUL AS AXL INHIBITORS AXL, TYRO3, MERTK TNF 4374/4885PDE4A 1910/4885PDE4B 1781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.